109
Views
22
CrossRef citations to date
0
Altmetric
Original Article

Foscarnet therapy for congenital cytomegalovirus liver fibrosis following prenatal ascites

, , , , , & show all
Pages 325-329 | Received 24 Nov 2003, Accepted 10 Dec 2003, Published online: 24 May 2010

REFERENCES

  • Stagno S. Cytomegalovirus. In Remington JS, Klein JO, eds. Infectious Diseases of the Fetus and Newborn Infant, 5th edn. Philadelphia: WB Saunders, 2001:389–424
  • Fowler KB, Stagno S, Pass RF, et at. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med 1992;326:663–7
  • Nigro G, Mazzocco M, Anceschi MM, et at. Prenatal diagnosis of fetal cytomegalovirus infection after primary or recurrent maternal infection. Obstet Gynecol 1999;94:909–14
  • Boppana SB, Fowler KB, Britt WJ, et at. Symptomatic congenital cytomegalovirus infection in infants born to mothers with pre-existing immunity to cytomegalovirus. Pediatrics 1999;104:55–60
  • Nigro G, Krzysztofiak A, Bartmann U, et at. Ganciclovir therapy for cytomegalovirus-associated liver disease in immunocompetent or immunocompromised children. Arch Virol 1997;142:573–80
  • Tajiri H, Kozaiwa K, Tanaka-Taya K, et at. Cytomegalovirus hepatitis confirmed by in situ hybridization in 3 immunocom-petent infants. Scand J Infect Dis 2001;33: 790–3
  • Faulds D, Heel RC. Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections. Drugs 1990;39:597–638
  • Nigro G, Bartmann U, Mattia S, et at. Acute hepatitis in childhood: virological, immunological and clinical aspects. Biomed Pharmacother 1992;46:155–60
  • Nigro G, La Torre R, Mazzocco M, et at. Multi-system cytomegalovirus fetopathy by recurrent infection in a pregnant woman with hepatitis B. Prenat Diagn 1999;19:1070–2
  • Zaia JA. Pathogenesis of CMV-associated disease in 1990. Transplant 1991;23 (Suppl 3):1–4
  • Chrisp P, Clissold SP. Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis. Drugs 1991;41:104–29
  • Eckle T, Prix L, Jahn G, et at. Drug-resistant human cytomegalovirus infection in children after allogeneic stem cell transplantation may have different clinical outcomes. Blood 2000;96:3286–9
  • Ohta H, Matsuda Y, Tokimara S, et at. Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis after stem cell transplantation: effective monitoring of CMV infection by quantitative analysis of CMV mRNA. Bone Marrow Trans-plant 2001;27:1141–5

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.